Screener
Zymeworks ZYME EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Zymeworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001937653-26-000047
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other comprehensive (loss) income | (129) | 66 | (615) | 612 |
| Comprehensive (loss) income | $(45,148) | $2,383 | $(89,796) | $(19,707) |
| Net (loss) income per common share: | ||||
| Basic | $(0.62) | $0.03 | $(1.21) | $(0.27) |
| Diluted | $(0.62) | $0.03 | $(1.21) | $(0.27) |
| Weighted-average common stock outstanding: | ||||
| Basic | 72,993,313 | 75,337,168 | 73,826,423 | 75,254,553 |
| Diluted | 72,993,313 | 77,378,449 | 73,826,423 | 75,302,357 |
Item 1. Financial Statements
FAQ
- What is Zymeworks's EPS (diluted)?
- Zymeworks (ZYME) reported EPS (diluted) of -$0.62 in Q2 2026.
- How has Zymeworks's EPS (diluted) changed year-over-year?
- Zymeworks's EPS (diluted) decreased by 2166.7% year-over-year, from $0.03 to -$0.62.
- What is the long-term trend for Zymeworks's EPS (diluted)?
- Over 3 years (2022 to 2025), Zymeworks's EPS (diluted) has grown at a -16.9% compound annual growth rate (CAGR), from $1.88 to -$1.08.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Zymeworks's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude